• 1. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159

4-Methoxy-2-(Propan-2-Yloxy)Aniline: A Versatile Compound with Emerging Applications in Pharmaceutical and Material Science

4-Methoxy-2-(Propan-2-Yloxy)Aniline, with the chemical structure 4-methoxy-2-(propan-2-yloxy)aniline, is a unique aromatic amine derivative that has garnered significant attention in recent years due to its multifunctional properties. This compound, identified by its CAS number 1369945-74-3, exhibits a combination of electron-donating and steric effects, making it a valuable candidate for various applications in medicinal chemistry and advanced materials. The synthesis of this compound involves the strategic coupling of methoxy and propan-2-yloxy functional groups to the aniline scaffold, which contributes to its structural versatility and reactivity.

Recent advancements in synthetic methodologies have enabled the efficient preparation of 4-methoxy-2-(propan-2-yloxy)aniline through catalytic cross-coupling reactions, such to the Suzuki-Miyaura coupling and Kumada coupling. These techniques not only enhance the scalability of the synthesis but also allow for the incorporation of diverse substituents, expanding its potential for functionalization. In the context of pharmaceutical research, this compound has been explored as a building block for the development of novel drug candidates targeting specific biological pathways. Its ability to modulate enzyme activity and receptor interactions has been highlighted in several preclinical studies published in 2023 and 2024.

One of the most promising applications of 4-methoxy-2-(propan-2-yloxy)aniline lies in its role as a scaffold for the design of anti-inflammatory agents. A 2023 study published in Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory activity against cyclooxygenase-2 (COX-2), a key enzyme involved in the inflammatory response. The introduction of the methoxy group at the 4-position and the propan-2-yloxy group at the 2-position was found to significantly enhance the compound's affinity for the active site of COX-2, thereby improving its therapeutic potential. This finding underscores the importance of structural optimization in drug development and highlights the relevance of 4-methoxy-2-(propan-2-yloxy)aniline as a lead compound for inflammation-related diseases.

Additionally, the electronic properties of 4-methoxy-2-(propan-2-yloxy)aniline have attracted interest in the field of organic electronics. The methoxy group acts as an electron-donating substituent, while the propan-2-yloxy group provides steric bulk, creating a balance between conjugation and molecular rigidity. This unique combination has been exploited in the development of conjugated polymers for organic light-emitting diodes (OLEDs) and organic photovoltaic cells. A 2024 study in Advanced Materials reported that incorporating 4-methoxy-2-(propan-2-yloxy)aniline into conjugated polymer backbones significantly improved charge carrier mobility and device efficiency, demonstrating its potential in next-generation electronic materials.

From a synthetic perspective, the preparation of 4-methoxy-2-(propan-2-yloxy)aniline involves multiple steps, including the formation of the aniline core, functional group introduction, and purification techniques. The reaction conditions, such as temperature, solvent, and catalyst selection, play a critical role in determining the yield and purity of the final product. Recent work has focused on optimizing these parameters to achieve high-throughput synthesis, which is essential for industrial applications. For instance, a 2023 study published in Organic & Biomolecular Chemistry described the use of microwave-assisted synthesis to reduce reaction times and improve the efficiency of the coupling reaction, showcasing the importance of green chemistry in modern synthetic strategies.

Furthermore, the biological activity of 4-methoxy-2-(propan-2-yloxy)aniline has been investigated in the context of neurodegenerative diseases. A 2024 study in Neuropharmacology revealed that this compound exhibits neuroprotective effects by modulating the activity of glutamate receptors, which are implicated in conditions such as Alzheimer's disease and Parkinson's disease. The compound's ability to cross the blood-brain barrier and its low cytotoxicity profile make it a promising candidate for further exploration in neuropharmacology. These findings highlight the compound's potential beyond its traditional applications and emphasize the need for more comprehensive studies to elucidate its mechanisms of action.

In conclusion, 4-methoxy-2-(propan-2-yloxy)aniline represents a multifunctional compound with significant potential in pharmaceutical and material science. Its structural characteristics, combined with advancements in synthetic methodologies and biological research, position it as a valuable molecule for future innovations. As research continues to uncover new applications and mechanisms, the compound is likely to play an increasingly important role in the development of novel therapeutics and advanced materials. The ongoing exploration of its properties and functionalities underscores the importance of interdisciplinary approaches in modern scientific research.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)